Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q4 2024 vs. Q3 2024
How the institutions holding Kiora Pharmaceuticals Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 19 | 16 | −3 |
| Shares | 1.47M | 1.26M | −209.7K (−14.3%) |
| Value | $5.38M | $4.16M | −$1.21M (−22.6%) |
New holders (1)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $3 | 0.00% |
Sold out (4)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Alyeska Investment Group, L.P. | 180,780 | $661.7K |
| Susquehanna International Group, LLP | 11,382 | $41.7K |
| Citadel Advisors LLC | 10,114 | $37.0K |
| Sabby Management, LLC | 5,000 | $18.3K |